
Inmode Ltd (INMD) Stock Forecast & Price Target
Inmode Ltd (INMD) Analyst Ratings
Bulls say
InMode Ltd demonstrated strong operational performance in the second quarter of 2025, selling 971 systems and achieving a global installed base increase of 3.4% to approximately 28,855 units, including 12,347 units in the United States. The company also reported an operating margin of 27.5%, surpassing previous estimates and reflecting a year-over-year increase of 40 basis points. Additionally, InMode's domestic sales reached $49.7 million, marking a significant improvement with a 9% growth compared to a decline of 7% in the prior quarter, underscoring the robust demand in the expanding aesthetic market.
Bears say
InMode Ltd is facing a negative outlook due to anticipated contraction in its gross margins, despite currently holding some of the highest margins in the med tech sector. Additionally, its earnings per share (EPS) growth is projected to lag behind revenue growth, indicating potential inefficiencies in translating revenue gains into profit. Furthermore, the company's revenue compound annual growth rate (CAGR) is expected to be less than 5% over the coming years as a result of weaker performance from existing products and slower adoption of new technologies.
This aggregate rating is based on analysts' research of Inmode Ltd and is not a guaranteed prediction by Public.com or investment advice.
Inmode Ltd (INMD) Analyst Forecast & Price Prediction
Start investing in Inmode Ltd (INMD)
Order type
Buy in
Order amount
Est. shares
0 shares